Fibrinogen linked to dangerous low density lipoprotein (LDL)
This article was originally published in Clinica
Executive Summary
Fibrinogen is not just a marker for the risk of blood clotting, it is also linked to high levels of particularly dangerous forms of LDL and low HDL, say German researchers. Writing in the January issue of Arteriosclerosis, Thrombosis and Vascular Biology, Dr Martin Halle of the Freiburg Medical Clinic says individuals with elevated levels of fibrinogen should be advised to stay lean and fit and avoid saturated fatty acids.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.